These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 26269227)

  • 21. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.
    Morgan CJ; Freeman TP; Schafer GL; Curran HV
    Neuropsychopharmacology; 2010 Aug; 35(9):1879-85. PubMed ID: 20428110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.
    Galaj E; Xi ZX
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol.
    Kudrich C; Hurd YL; Salsitz E; Wang AL
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):569-581. PubMed ID: 34678050
    [No Abstract]   [Full Text] [Related]  

  • 27. Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties.
    Sharpe L; Sinclair J; Kramer A; de Manincor M; Sarris J
    J Transl Med; 2020 Oct; 18(1):374. PubMed ID: 33008420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?
    Lippiello P; Balestrini S; Leo A; Coppola A; Citraro R; Elia M; Russo E; De Sarro G
    Curr Pharm Des; 2016; 22(42):6426-6433. PubMed ID: 27587196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homegrown perceptions about the medical use and potential abuse of CBD and THC.
    McFadden BR; Malone T
    Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
    Nahler G
    Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can cannabidiol have an analgesic effect?
    Kulesza B; Mazurek M; Kurzepa J
    Fundam Clin Pharmacol; 2024 Feb; 38(1):33-41. PubMed ID: 37584368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Targets of Cannabidiol in Neurological Disorders.
    Ibeas Bih C; Chen T; Nunn AV; Bazelot M; Dallas M; Whalley BJ
    Neurotherapeutics; 2015 Oct; 12(4):699-730. PubMed ID: 26264914
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Canseco-Alba A; Rodríguez-Manzo G
    Rev Invest Clin; 2023; 75(3):105-128. PubMed ID: 37441766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
    Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
    Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
    Khalid S; Almalki FA; Hadda TB; Bader A; Abu-Izneid T; Berredjem M; Elsharkawy ER; Alqahtani AM
    Curr Pharm Des; 2021; 27(13):1564-1578. PubMed ID: 33267756
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.